{
    "nct_id": "NCT03665077",
    "official_title": "Pilot Trial to Evaluate Blood and Imaging Based Biomarkers for Aromatase Inhibitor Induced Musculoskeletal Syndrome",
    "inclusion_criteria": "1. Be capable of understanding the investigational nature of the study and all pertinent aspects of the study\n2. Be capable of signing and providing written consent in accordance with institutional and federal guidelines\n3. Have a histologically-confirmed diagnosis of breast cancer\n4. Be willing and able to comply with scheduled visits, treatment plan, and SWE ultrasound imaging\n5. Age ≥ 21 years\n6. Post-menopausal women with 1st event of ER+ early stage breast cancer (0-3)\n7. Completed definitive therapy (surgery ± radiation)\n8. Candidates for adjuvant AI therapy\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 21 Years",
    "exclusion_criteria": "1. Have received adjuvant or neo-adjuvant chemotherapy\n2. Prior endocrine therapy (AI or tamoxifen)\n3. History of rheumatoid arthritis or other autoimmune arthritis\n4. Daily non-steroidal anti-inflammatory drug (NSAID) use (except for daily aspirin use)\n5. Current use of daily corticosteroids or immunosuppressive therapies",
    "miscellaneous_criteria": ""
}